Proteomic analysis of anti‐angiogenic effects by a combined treatment with vinblastine and rapamycin in an endothelial cell line
- 3 August 2006
- journal article
- research article
- Published by Wiley in Proteomics
- Vol. 6 (15) , 4420-4431
Abstract
Angiogenesis controls the new blood supply routes into the tumor mass via the host endothelial cells (ECs). In this study, the EA.hy926 endothelial cell line has been treated with vinblastine (VBL) and rapamycin (RAP), both separately and in combination at low doses. Recently, we demonstrated the synergistic antiangiogenic effects of a combination of VBL and RAP at very low doses in vitro and in vivo. Herein, we confirm the ability of this combined treatment to statistically inhibit the proliferation of ECs, in a synergistic manner, by inducing apoptosis. The aim of this study was to substantiate these findings at the protein level. Differential proteomic analysis was performed on untreated control cells, treated with VBL, incubated with RAP, or subjected to a drug combination. Differentially expressed 113 polypeptide chains were visualized and 65 were identified via MALDI‐TOF analysis. Some of the regulated proteins are involved in the processes of angiogenesis, proliferation, migration, and apoptosis. The down‐modulation of ATP synthase, annexin A2, heat shock p70, glucose‐6‐phosphate dehydrogenase, vasodilator‐stimulated phosphoprotein, proteasome 26S, tryptophanyl‐tRNA synthetase, and stathmin/OP18, as well as the up‐modulation of carbonyl reductase, Rho‐GDI, and histone H1.0 correlates with the synergistic antiangiogenic activity of VBL and RAP.Keywords
This publication has 36 references indexed in Scilit:
- Synergistic inhibition of human neuroblastoma-related angiogenesis by vinblastine and rapamycinOncogene, 2005
- Proteomics Today2005
- Annexins: From Structure to FunctionPhysiological Reviews, 2002
- Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factorNature Medicine, 2002
- ‘Accidental’ anti-angiogenic drugsEuropean Journal of Cancer, 2000
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996
- The implications of angiogenesis for the biology and therapy of cancer metastasisCell, 1994
- Quantification of cells cultured on 96-well platesAnalytical Biochemistry, 1989
- Permanent cell line expressing human factor VIII-related antigen established by hybridization.Proceedings of the National Academy of Sciences, 1983
- Transplacental Carcinogenesis by StilbestrolNew England Journal of Medicine, 1971